Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kite Pharma Inc (NASDAQ:KITE)

55.98
Delayed Data
As of Sep 29
 -0.48 / -0.85%
Today’s Change
38.41
Today|||52-Week Range
89.84
-9.15%
Year-to-Date
Company News for September 28, 2016
Sep 28 / Zacks.com - Paid Partner Content
Kite Pharma (KITE) Stock Surges on Lymphoma Trial, Cowen: Drug's Efficacy 'Impressive...
Sep 27 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data
Sep 28 / Zacks.com - Paid Partner Content
Why Kite Pharma's Stock Is Soaring Today
Sep 27 / MotleyFool.com - Paid Partner Content
How Kite Pharma Could Change Cancer Treatment Forever
Sep 27 / MotleyFool.com - Paid Partner Content
3 After-Hours Movers: Earnings & Clinical Data Pushing Stocks Up
Sep 26 / Benzinga - Paid Partner Content
Here's Why Juno Therapeutics Is Shooting 10% Higher Today
Sep 27 / MotleyFool.com - Paid Partner Content
Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next
Sep 26 / TheStreet.com - Paid Partner Content
Kite Pharma Reports Favorable Data from Lymphoma Study
Sep 27 / Zacks.com - Paid Partner Content
Juno Therapeutics and Kite Pharma: The Danger of Alarmingly Thin Data
Sep 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close56.46
Today’s open56.40
Day’s range55.75 - 56.98
Volume1,164,468
Average volume (3 months)918,419
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-21.99%
Earnings growth (this year)-147.77%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales155.81
Price/Book4.46

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.43-3.04%
BLUEbluebird bio Inc-2.70-3.91%
RDUSRadius Health Inc-2.93-5.04%
NKTRNektar Therapeutics-0.72-4.07%
Data as of 3:59pm ET, 09/29/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$1.60
Annual revenue (last year)$17.3M
Annual profit (last year)-$101.7M
Net profit margin-589.02%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Arie S. Belldegrun
Chief Operating Officer
Cynthia M. Butitta
Corporate headquarters
Santa Monica, California

Forecasts

Search for Jobs